Funding

London-based Goodrays Secures €5.7 Million In Series A Round

Jul 11, 2025 | By Kailee Rainse

Goodrays, a fast-growing UK CBD drinks brand, has raised €5.7 million in a Series A round, combining equity and debt financing.

SUMMARY

  • Goodrays, a fast-growing UK CBD drinks brand, has raised €5.7 million in a Series A round, combining equity and debt financing.

The round included investment from Guinness Ventures, as well as support from existing and new institutional investors and celebrity backers like Vernon Kay, Tess Daly, Ed Leigh, and Ben Skinner.

The funding comes alongside the appointment of Ben Dando, former International Managing Director at Liquid Death, as Goodrays' new Managing Director.

“This round is a huge milestone on our mission to build the UK’s leading premium functional drinks brand. We exist to help busy minds find calm and clarity and we’re proud to create the most effective and premium functional drinks for people who want to improve their mental wellbeing. For too long, mental wellbeing has been ignored by the food and drink industry, dominated by high sugar, hard alcohol and ultra-processed foods. We are changing that,” said Eoin Keenan, Founder of Goodrays.

“The support from Guinness Ventures, renowned for their expertise in building iconic brands, combined with Ben’s proven track record, positions us perfectly for our next phase of growth and to continue to cement ourselves as a disruptor in the industry,” Keenan added.

Founded in 2020 Goodrays has doubled its revenue and profitability year-on-year for three straight years. In 2024 the brand reached a major milestone by securing listings with four of the UK’s largest retailers, cementing its place in the premium CBD and functional drinks market.

Read Also - Swiss BioTech Platform NUCLIDIUM Secures €84 Million In Series B Round

The recent investment comes at a critical time, as the UK CBD market—valued at €799 million in 2021—is expected to grow to €1.1 billion by the end of this year. With full market authorisation for CBD products anticipated in early 2026, the industry is on the cusp of a regulatory breakthrough. Goodrays plans to use the new funding for product innovation, marketing expansion, and retail growth.

The brand will focus on launching top-tier products, boosting brand visibility, and strengthening retail partnerships. Ben Dando who advised the company in 2024 and formerly led international operations at Liquid Death, has now joined as Managing Director, bringing deep expertise to support Goodrays' next phase of growth through bold marketing and strategic collaborations.

“Goodrays isn’t just another functional drinks brand – we’re here to provide a solution and create a legacy brand,” said Ben Dando, incoming Managing Director. “While others obsess over what to cut out, we’re focused on what benefits we can add in, especially when it comes to peoples’ mental wellbeing – something which we believe has long been overlooked in the drinks industry. We’re at a tipping point in how consumers engage with the drinks industry, and right now, the functional drinks category is the most exciting and fast-moving space in food and drink.”

About Goodrays

Goodrays creates CBD products designed to calm an active mind and offer moments of clarity. Made for the curious, creative, brave, and bold, Goodrays helps people relax, refocus, and feel balanced—whenever they need it most.

Recommended Stories for You